Get the latest Science News and Discoveries

Regeneron joins Trump to announce lower drug prices, quick FDA approval

The FDA Thursday granted expedited approval to Regeneron's gene therapy treatment for genetic hearing loss.

None

Related news:

Trump administration officially reclassifies state-licensed medical marijuana as Schedule III

'That's just not a winning strategy': Congress objects (again) to Trump's planned NASA budget cuts

Pace of N.I.H. Funding Slows Further in Trump’s Second Year